CELGENE

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
>
Registration as it was on 08 Oct 2015
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

350,000€

Financial year: Jan 2014 - Dec 2014

Lobbyists (Full time equivalent)

1.75 Fte (4)

Lobbyists with EP accreditation

4

High-level Commission meetings

6

Lobbying Costs over the years

  • Info

    CELGENE

    EU Transparency Register

    37955905654-37 First registered on 14 Apr 2011

    Goals / Remit

    Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing therapies for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other serious diseases.

    Main EU files targeted

    Celgene works with European institutions to raise awareness of diseases with a high unmet medical need - such as rare diseases, rare cancers and immune and inflammatory diseases - to drive greater focus on patients with these underserved conditions. We seek cooperation in policy developments that improve regulatory processes for pharmaceuticals and ensure the right environment for research and industry in Europe. We foster debates around improved and equal access to innovative medicines for patients through open dialogues with European policy-makers.

    We are monitoring the revision of the implementing guidelines on orphan drug designation; the follow-up actions of Council recommendations on an action in the field of rare diseases (2009/C 151/02); the setting-up of the European Commission initiative on rare cancers; the implementation of the Clinical Trials Regulation (536/2014); the debates and initiatives on international reference pricing of medicines; European cooperation mechanisms on Health Technology Assessment such as EUnetHTA; the potential revision of the Regulation on Advanced Therapy Medicinal Products (1394/2007); and the follow-up on the Staff Working Document: "Pharmaceutical Industry: A Strategic Sector for the European Economy".

    Address

    Head Office
    Morris Avenue, 86
    Summit NJ07901
    UNITED STATES
    EU Office
    Parc de l'Alliance, Batiment A
    Boulevard de France, 9
    Braine l'Alleud 1420
    BELGIUM
  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    50%3
    25%1

    Lobbyists (Full time equivalent)

    1.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    4 accreditations were / are live (in bold) for the selected state of 08 Oct 2015

    Name Start date End Date
    Ms Esther BERDEN 21 Feb 2020 09 Apr 2020
    Mr Erwan Gicquel 16 Jan 2020 09 Apr 2020
    Mr Emmanuel Chantelot 18 Dec 2019 09 Apr 2020
    Mr Silviu Popa 17 Oct 2019 09 Apr 2020
    Ms Cassandre Sergent 20 Sep 2019 09 Apr 2020
    Ms Esther BERDEN 19 Feb 2019 19 Feb 2020
    Mr Erwan Gicquel 22 Jan 2019 16 Jan 2020
    Mr Emmanuel Chantelot 22 Jan 2019 18 Dec 2019
    Ms Cassandre Sergent 01 Sep 2018 31 Aug 2019
    Mr Silviu Popa 14 Jun 2018 14 Jun 2019
    Mr Adam PARNABY 31 Jan 2018 31 Jan 2019
    Mr Erwan Gicquel 08 Dec 2017 07 Dec 2018
    Mr Emmanuel Chantelot 28 Nov 2017 28 Nov 2018
    Ms Cassandre Sergent 31 Aug 2017 25 Aug 2018
    Mr Silviu Popa 20 Jul 2017 14 Jun 2018
    Mr Erwan Gicquel 16 Dec 2016 08 Dec 2017
    Mr Emmanuel Chantelot 01 Nov 2016 01 Nov 2017
    Ms Cassandre Sergent 30 Aug 2016 27 Aug 2017
    Ms Laura GUTIERREZ 19 Jul 2016 02 Jul 2017
    Mr Silviu Popa 19 Jul 2016 02 Jul 2017
    Ms Lugdivine Le Dez 19 Jul 2016 28 Jun 2017
    Mr Christoph GLIESING 10 Oct 2015 14 Sep 2016
    Ms Laura GUTIERREZ 05 Jun 2015 03 Jun 2016
    Mr Silviu Popa 05 Jun 2015 03 Jun 2016
    Ms Caroline Correas 14 Nov 2014 10 Oct 2015
    Ms Lugdivine Le Dez 14 Nov 2014 12 Nov 2015
    Ms Laura GUTIERREZ 29 Jul 2014 05 Jun 2015
    Serge De Ruysscher 26 Jun 2014 23 Apr 2015
    Mr Silviu Popa 14 Jun 2014 05 Jun 2015
    Ms Lugdivine Le Dez 28 Nov 2013 14 Nov 2014
    Ms Caroline Correas 01 Nov 2013 31 Oct 2014
    Mr Julien Patris 21 Aug 2013 15 Aug 2014
    Ms Laura GUTIERREZ 30 Jul 2013 27 Jul 2014
    Mrs Cassandra Elsa Birgitta JULIN 11 Jan 2013 30 Mar 2013
    Mrs Cassandra Elsa Birgitta JULIN 06 Feb 2012 01 Nov 2012
    Mrs Laura GUTIERREZ 06 Feb 2012 01 Aug 2012
    Mr Julien Claude PATRIS 24 Jan 2012 08 Feb 2013

    Complementary Information

    While several Celgene employees contribute to the company’s activities falling under the scope of the Transparency Register, only 4 Celgene employees spend more than 10% of their respective work time on this.

    Person in charge of EU relations

    Ms Laura Gutierrez de la Iglesia (Director EU Government Relations)

    Person with legal responsibility

    Mr Tuomo Patsi (President EMEA)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    Celgene is a member of following organizations in Brussels:
    European Federation of Pharmaceutical Industries and Associations (EFPIA)
    EFPIA/EuropaBio (European Association of Bio-Industries) Joint Taskforce on Rare Diseases and Orphan Medicinal Products
    European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
    European Biopharmaceutical Enterprises (EBE)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2014 - Dec 2014

    Lobbying costs for closed financial year

    350,000€

    Other financial info

    The estimated costs of Celgene arising from activities for the year 2014 covered by the Register include staff costs based on the full-time equivalents already declared, payment to third parties (e.g. fees for consultants) and membership and related fees for joining relevant networks and structures (e.g. trade associations).
    This new estimate follows and is consistent with the guidance provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    6 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 30 Nov 2017 Location Brussels
      Subject Investment, innovation and IP protection
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Jyrki Katainen (Vice-President)
    • Date 29 Nov 2017 Location Brussels
      Subject Pharmaceutical incentives, antimicrobial resistance
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 27 Nov 2015 Location Brussels
      Subject Biopharmaceutical industry's contribution to jobs and growth
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Grzegorz Radziejewski (Cabinet member)
      Other Lobbyists
    • Date 27 Apr 2015 Location Brussels, Belgium
      Subject Biopharmaceutical industry
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Kaius Kristian Hedberg (Cabinet member)
      • Rolf Carsten Bermig (Cabinet member)
    • Date 04 Feb 2015 Location Brussels
      Subject Access to innovative medicine
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 04 Feb 2015 Location Brussels
      Subject Janssen EMEA
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Aura Salla (Cabinet member)
Download this datacard